Clinical Trial Update: Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating valproic acid in combination with the FEC100 chemotherapy regimen as primary therapy for breast cancer was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-03-09